It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.

Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

Our analysis of options history for Thermo Fisher Scientific TMO ... revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and ...

Thermo Fisher Scientific (NYSE:TMO – Free Report) had its price objective upped by UBS Group from $700.00 to $715.00 in a research note released on Friday morning,Benzinga reports. The brokerage ...

Strong demand, biotech funding optimism, and a bold 2025 outlook fuel investor confidence--here's what you need to know.

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $654.0, with a high estimate of $680.00 and a low estimate of $605.00. Experiencing a 1.36% ...

Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.